LOW LEVELS OF GROWTH DIFFERENTIATION FACTOR 11 AND HIGH LEVELS OF ITS INHIBITOR FOLLISTATIN-LIKE 3 ARE ASSOCIATED WITH ADVERSE CARDIOVASCULAR OUTCOMES IN HUMANS

LOW LEVELS OF GROWTH DIFFERENTIATION FACTOR 11 AND HIGH LEVELS OF ITS INHIBITOR FOLLISTATIN-LIKE 3 ARE ASSOCIATED WITH ADVERSE CARDIOVASCULAR OUTCOMES IN HUMANS

Methods: We measured plasma GDF11 and FSTL3 levels in 928 subjects with stable coronary heart disease (CHD) from the Heart and Soul Study cohort using modified aptamer-based proteomics.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2015-03, Vol.65 (10), p.A999-A999
Hauptverfasser: Heidecker, Bettina, Olson, Kristoff, Beatty, Alexis, Dubin, Ruth, Kato, Shintaro, Lawn, Richard, Murthy, Ashwin, Regan, Mathilda, Sterling, David, Whooley, Mary, Ganz, Peter
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Cardiovascular
Cardiovascular disease
Heart attacks
Internal Medicine
Medical research
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Methods: We measured plasma GDF11 and FSTL3 levels in 928 subjects with stable coronary heart disease (CHD) from the Heart and Soul Study cohort using modified aptamer-based proteomics.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(15)60999-8